CRITICAL VAX FOR KOALAS

HUNDREDS of koalas will trial a new chlamydia vaccine that may play a significant part in the long-term survival of the species.

It is estimated the disease affects more than half of koala populations in Australia, particularly in NSW and South East Queensland.

The vaccine, developed by the University of the Sunshine Coast, has passed two phases of testing, making it safe for koalas.

USC professor of microbiology Peter Timms said the vaccine produced a good immune response and level of protection and was now ready for phase 3.

“While this vaccination will directly benefit each of the animals, the trial will focus on the protection provided by vaccination,” he said.

“All koalas will be microchipped and the hospital will record animals that return over the following year.”